Loading...
Loading...
Among the 6 tracked institutional investors we monitor, ELDN (ELEDON PHARMACEUTICALS INC) is held with a combined value of $23.39M across 9,651,822 shares. The largest holder is BlackRock, Inc. with a position worth $13.50M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$23.39M
Total Shares Held
9,651,822
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $13.50M | 0.00% | +20.8% |
| 2 | VANGUARD GROUP INC | $6.10M | 0.00% | New |
| 3 | STATE STREET CORP | $3.56M | 0.00% | +49.2% |
| 4 | CITADEL ADVISORS LLC | $138.60K | 0.00% | -43.8% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $75.77K | 0.00% | -86.1% |
| 6 | FMR LLC | $17.31K | 0.00% | +19.9% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of ELDN with a position worth $13.50M, representing 0.00% of their portfolio. In total, 6 institutional investors hold ELDN with a combined value of $23.39M.
In the most recent quarter, 1 fund opened a new position in ELDN. Additionally, 3 increased their holdings and 2 reduced their positions.
Institutional investors hold $23.39M worth of ELDN stock across 6 positions. The largest institutional holder is BlackRock, Inc. with $13.50M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ELDN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ELDN positions.